Stroke is a leading cause of death and disability in the United States and worldwide,
necessitating comprehensive efforts to optimize stroke risk factor management. Health …

In heart failure (HF) strong haemodynamic and neuronal signalling feedback interactions
between the heart and the central nervous system (CNS) exist that are able to mutually …

Heart failure (HF) is a major disease in our society that often presents with multiple
comorbidities with mutual interaction and aggravation. The comorbidity of HF and stroke is a …

One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …

BACKGROUND: The rate of stroke in patients with heart failure (HF) and preserved ejection
fraction but without atrial fibrillation (AF), is uncertain as is whether it is possible to reliably …

Introduction. Cardiac imaging is one of the main components of the etiological investigation
of ischemic strokes. However, basic and advanced cardiac imaging remain underused in …

Backgrounds Patients with acute heart failure (AHF) possess a high risk for
thromboembolism, and thromboembolism prophylaxis using heparin has been …

An alternative antiplatelet agent which is gathering increasing interest is cilostazol. The
Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS) trial reported that …

One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …

Heart failure (HF) is a major disease in our society that often presents with multiple
comorbidities with mutual interaction and aggravation. The comorbidity of HF and stroke is a …